Compare GPMT & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | STIM |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 105.5M |
| IPO Year | 2017 | 2018 |
| Metric | GPMT | STIM |
|---|---|---|
| Price | $2.44 | $1.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $3.13 | ★ $7.00 |
| AVG Volume (30 Days) | 183.1K | ★ 1.2M |
| Earning Date | 02-12-2026 | 11-04-2025 |
| Dividend Yield | ★ 8.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $129,873,000.00 |
| Revenue This Year | N/A | $101.67 |
| Revenue Next Year | $21.74 | $10.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 78.61 |
| 52 Week Low | $1.61 | $1.25 |
| 52 Week High | $3.19 | $5.92 |
| Indicator | GPMT | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 34.38 | 41.10 |
| Support Level | $2.41 | $1.34 |
| Resistance Level | $2.55 | $1.64 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 13.34 | 23.81 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.